Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis

被引:1
|
作者
Watson, HR
Robb, R
Belcher, G
Belch, JJF
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Med, Dundee DD1 9SY, Scotland
[2] Takeda Europe, R&D Ctr, Drug Safety, Frankfurt, Germany
关键词
Raynaud's phenomenon; systemic sclerosis; season; temperature;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective, Patients with systemic sclerosis (SSc) were assessed for 12 months to quantify the seasonal variation in Raynaud's phenomenon (RP) in patients with an underlying connective tissue disease. Methods. Eighteen patients with SSc (17 limited, 1 diffuse type) were studied. Raynaud's attacks were recorded in a daily diary for four 2-week periods at 3 month intervals, Daily number and duration of attacks and overall severity of RP were calculated for each 2-week period. Mean daily temperatures, measured and perceived, were obtained for each period. Results, In winter, patients had a mean of 2.9 attacks/day (SD +/- 1.1), daily duration 70 minutes (SD +/- 48) and a severity of score of 4.1 (SD +/- 2.0) out of 10. All 3 variables correlated with ambient outdoor temperature and varied significantly over the 12 months (p < 0.001) with mean reductions of 48, 50, and 56% respectively from winter to summer. Only 3 of 18 patients reported no attacks during the summer period. The mean measured and perceived outdoor temperatures increased from winter to summer by 10.6 and 14.3 degrees C, respectively. Conclusion. For patients with SSc, RP is a problem throughout the year. Symptoms may be reduced by about 50% in the summer months, but few patients experience complete relief.
引用
收藏
页码:1734 / 1737
页数:4
相关论文
共 50 条
  • [21] Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis
    Alexandra Balbir-Gurman
    Yolanda Braun-Moscovici
    Vladimir Livshitz
    Daniel Schapira
    Doron Markovits
    Alexander Rozin
    Tatiana Boikaner
    A. Menahem Nahir
    Clinical Rheumatology, 2007, 26 : 1517 - 1521
  • [22] Points to consider-Raynaud's phenomenon in systemic sclerosis
    Cutolo, Maurizio
    Smith, Vanessa
    Furst, Daniel E.
    Khanna, Dinesh
    Herrick, Ariane L.
    RHEUMATOLOGY, 2017, 56 : V45 - V48
  • [23] Systemic sclerosis and Raynaud's phenomenon: Comparison of clinical groups
    Andersone, D
    Spridzane, I
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 59 - 59
  • [24] Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis
    Botzoris, Vasileios
    Drosos, Alexandros A.
    JOINT BONE SPINE, 2011, 78 (04) : 341 - 346
  • [25] Outdoor temperatures and Raynaud's phenomenon in patients with systemic sclerosis
    Cutolo, Maurizio
    Smith, Vanessa
    Hysa, Elvis
    LANCET RHEUMATOLOGY, 2024, 6 (10): : e655 - e657
  • [26] Use of Heated Gloves for Raynaud's Phenomenon in Systemic Sclerosis
    Kumar, Kimti
    Matardiah, Nor Hashimah Abu Mansor
    Griggs, Kim
    Kunnel, Aline
    Walker, Jennifer
    Proudman, Susanna
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1245 - 1247
  • [27] The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis
    Pauling, J. D.
    O'Donnell, V. B.
    Mchugh, N. J.
    PLATELETS, 2013, 24 (07) : 503 - 515
  • [28] Angiogenic factors in autoimmune Raynaud's phenomenon and systemic sclerosis
    Black, C
    JOURNAL OF VASCULAR RESEARCH, 1999, 36 (02) : 169 - 169
  • [29] Plasma S-nitrosothiols in systemic sclerosis and Raynaud's phenomenon
    Kundu, Devi
    Abraham, David J.
    Black, Carol
    Bruckdorfer, Richard K.
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2012, 27 : S40 - S41
  • [30] Controlled trial of tadalafil in Raynaud phenomenon (RP) secondary to systemic sclerosis (SSc).
    Schiopu, Elena
    Hsu, Vivien M.
    Impens, Ann J.
    Guerriere-Rothman, Jennifer A.
    McCloskey, Deborah A.
    Seibold, James R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S523 - S523